| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.065 | 0.3 |